NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Ulcerative colitis
Date of first enrollment	23/03/2010
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : AJG501 INN of investigational material : Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : oral control material(s) Generic name etc : Placebo INN of investigational material : Therapeutic category code : --- Other Dosage and Administration for Investigational material : oral

Outcome(s)

Primary Outcome	Revised Sutherland DAI Proportion of relapse-free
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 16age old
Age maximum	<= 64age old
Gender	Both
Include criteria	UC in remission Patients who received at least 1 treatment for induction of remission within the past 48 weeks. Patients who diagnosed as mild to moderate UC in the nearest flare. Patients who are in remission for 4 weeks or more.
Exclude criteria